AHA 2015
Apixaban vs. Warfarin: Effects Compared in AF Patients With, Without PAD
Researchers conducted a post hoc analysis of the ARISTOTLE trial which included patients with atrial fibrillation (AF) and a risk of stroke treated with either apixaban or warfarin for the prevention of stroke/ systemic embolism.